Mycophenolate mofetil reduces severe flares and lower lupus nephritis incidence in patients with early-stage systemic lupus erythematosus
Study reveals CARD9/neutrophil signaling axis as a key driver of IL-17A-mediated ankylosing spondylitis
Ambrisentan reduces risk of pulmonary arterial hypertension in systemic sclerosis patients, study finds
Post-hoc analysis demonstrates the efficacy of tofacitinib in ankylosing spondylitis regardless of baseline C-reactive protein levels
Phase 2b RISE-SSc trial reveals potential predictors of response to riociguat in early diffuse cutaneous systemic sclerosis
